Northwestern University hasn’t received any funding from the NIH since the end of March. Not only could patients potentially ...

Empatica, a pioneer in digital biomarker development and patient monitoring using wearables and AI, today unveiled ...

Glucotrack reported positive clinical results for its implantable glucose monitor, aiming to offer a less-intrusive option ...

Neuron23® Inc., a clinical-stage biotechnology company focused on developing precision medicines for genetically defined ...

The first person with multiple sclerosis was imaged in a clinical trial of a PET tracer to track myelin changes.

Explore how digital biomarkers are transforming clinical trials with real-time data, continuous monitoring and AI-driven ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has dosed its first patient in the ...

Skyhawk Therapeutics has dosed the first subject in the randomised Phase II/III FALCON-HD trial of the oral small-molecule ...

Streeting has also promised to reduce the time it takes to get clinical trials approved by cutting red tape, pointing out ...

A panelist discusses how the COAT trial demonstrated that twice-daily 0.09% cyclosporine improves multiple signs and symptoms ...